PRF1 and neoplasm: In comparison to placebo, QBKPN administration increased granzyme B (GzmB), granzyme A (GzmA), and perforin (Prf1) expression in the lungs (Fig. 5B) of B16F10 tumor-bearing mice, which were associated with a decrease in tumor burden.